A synthetic peptide for use as a blocking control in assays to test for specificity of MAP4 antibody, Alternative Names: MAP4 control peptide, MAP4 antibody Blocking Peptide, Anti-MAP4 Blocking Peptide, microtubule-associated protein 4 Blocking Peptide, DKFZp779A1753 Blocking Peptide, MGC8617 Blocking Peptide, MAP4, MAP-4, MAP 4, MAP-4 Blocking Peptide, MAP 4 Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
MAP4
(Microtubule-Associated Protein 4 (MAP4))
Synonyme
XMAP4 Peptide, mtap4 Peptide, AA407148 Peptide, MAP-4 Peptide, Mtap-4 Peptide, Mtap4 Peptide, microtubule associated protein 4 Peptide, microtubule associated protein 4 L homeolog Peptide, microtubule-associated protein 4 Peptide, MAP4 Peptide, map4.L Peptide, Map4 Peptide
Hintergrund
MAP4 is a major non-neuronal microtubule-associated protein. This protein contains a domain similar to the microtubule-binding domains of neuronal microtubule-associated protein (MAP2) and microtubule-associated protein tau (MAPT/TAU). This protein promotes microtubule assembly, and has been shown to counteract destabilization of interphase microtubule catastrophe promotion. Cyclin B was found to interact with this protein, which targets cell division cycle 2 (CDC2) kinase to microtubules. The phosphorylation of this protein affects microtubule properties and cell cycle progression.